Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Incidence and predictors of all-cause and site-specific cancer in type 2 diabetes: the Fremantle Diabetes Study.

Magliano DJ, Davis WA, Shaw JE, Bruce DG, Davis TM.

Eur J Endocrinol. 2012 Oct;167(4):589-99. doi: 10.1530/EJE-12-0053. Epub 2012 Aug 14.

2.

Incidence and predictors of hospitalization for bacterial infection in community-based patients with type 2 diabetes: the fremantle diabetes study.

Hamilton EJ, Martin N, Makepeace A, Sillars BA, Davis WA, Davis TM.

PLoS One. 2013;8(3):e60502. doi: 10.1371/journal.pone.0060502. Epub 2013 Mar 25.

3.

Incidence and predictors of hospitalization for tendon rupture in type 2 diabetes: the Fremantle diabetes study.

Zakaria MH, Davis WA, Davis TM.

Diabet Med. 2014 Apr;31(4):425-30. doi: 10.1111/dme.12344. Epub 2013 Nov 16.

PMID:
24151882
4.

Incidence and precipitants of hospitalization for pancreatitis in people with diabetes: the Fremantle Diabetes Study.

Davis TM, Drinkwater J, Davis WA.

Diabet Med. 2014 Aug;31(8):913-9. doi: 10.1111/dme.12448. Epub 2014 Apr 8.

PMID:
24661305
5.

Risk of colorectal cancer in type 2 diabetic patients: a population-based cohort study.

Wang JY, Chao TT, Lai CC, Wang CY, Wu VC, Wang SM, Lin HI, Tang SH, Lin HW.

Jpn J Clin Oncol. 2013 Mar;43(3):258-63. doi: 10.1093/jjco/hys228. Epub 2013 Jan 3.

PMID:
23288931
6.

Prevalence, incidence, and prognosis of hepatobiliary disease in community-based patients with type 2 diabetes: the Fremantle Diabetes Study.

Davis TM, Peters KE, Bruce DG, Davis WA.

J Clin Endocrinol Metab. 2012 May;97(5):1581-8. doi: 10.1210/jc.2011-3232. Epub 2012 Feb 22.

PMID:
22362822
7.

The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity.

Peeters PJ, Bazelier MT, Leufkens HG, de Vries F, De Bruin ML.

Diabetes Care. 2015 Mar;38(3):495-502. doi: 10.2337/dc14-1175. Epub 2014 Dec 31.

PMID:
25552419
8.
9.

Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals.

Carstensen B, Read SH, Friis S, Sund R, Keskimäki I, Svensson AM, Ljung R, Wild SH, Kerssens JJ, Harding JL, Magliano DJ, Gudbjörnsdottir S; Diabetes and Cancer Research Consortium.

Diabetologia. 2016 May;59(5):980-8. doi: 10.1007/s00125-016-3884-9. Epub 2016 Feb 29.

10.

Oral insulin secretagogues, insulin, and cancer risk in type 2 diabetes mellitus.

Chang CH, Lin JW, Wu LC, Lai MS, Chuang LM.

J Clin Endocrinol Metab. 2012 Jul;97(7):E1170-5. doi: 10.1210/jc.2012-1162. Epub 2012 May 4.

PMID:
22563104
11.

Increased cancer incidence risk in type 2 diabetes mellitus: results from a cohort study in Tyrol/Austria.

Oberaigner W, Ebenbichler C, Oberaigner K, Juchum M, Schönherr HR, Lechleitner M.

BMC Public Health. 2014 Oct 10;14:1058. doi: 10.1186/1471-2458-14-1058.

12.

Influence of Premature Mortality on the Link Between Type 2 Diabetes and Hip Fracture: The Fremantle Diabetes Study.

Hamilton E, Davis WA, Bruce DG, Davis TM.

J Clin Endocrinol Metab. 2017 Feb 1;102(2):551-559. doi: 10.1210/jc.2016-3570.

PMID:
27880070
13.

Fasting serum glucose level and cancer risk in Korean men and women.

Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM.

JAMA. 2005 Jan 12;293(2):194-202.

PMID:
15644546
14.

Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias.

Johnson JA, Bowker SL, Richardson K, Marra CA.

Diabetologia. 2011 Sep;54(9):2263-71. doi: 10.1007/s00125-011-2242-1. Epub 2011 Jul 12.

PMID:
21748485
15.

Italian cancer figures, report 2013: Multiple tumours.

AIRTUM Working Group.

Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152. English, Italian.

16.
17.

Prevalence, risk factors and sequelae of Staphylococcus aureus carriage in diabetes: the Fremantle Diabetes Study Phase II.

Hart J, Hamilton EJ, Makepeace A, Davis WA, Latkovic E, Lim EM, Dyer JR, Davis TM.

J Diabetes Complications. 2015 Nov-Dec;29(8):1092-7. doi: 10.1016/j.jdiacomp.2015.06.005. Epub 2015 Jun 16.

PMID:
26243688
18.

Risk of Malignant Neoplasms of Kidney and Bladder in a Cohort Study of the Diabetic Population in Taiwan With Age, Sex, and Geographic Area Stratifications.

Chen HF, Chen SW, Chang YH, Li CY.

Medicine (Baltimore). 2015 Sep;94(38):e1494. doi: 10.1097/MD.0000000000001494.

19.

Increased risk of cancer in patients with type 2 diabetes mellitus: a retrospective cohort study in China.

Zhang PH, Chen ZW, Lv D, Xu YY, Gu WL, Zhang XH, Le YL, Zhu HH, Zhu YM.

BMC Public Health. 2012 Jul 28;12:567. doi: 10.1186/1471-2458-12-567.

20.

Detection bias may be the main cause of increased cancer incidence among diabetics: results from the Rotterdam Study.

De Bruijn KM, Ruiter R, de Keyser CE, Hofman A, Stricker BH, van Eijck CH.

Eur J Cancer. 2014 Sep;50(14):2449-55. doi: 10.1016/j.ejca.2014.06.019. Epub 2014 Jul 18.

PMID:
25047425

Supplemental Content

Support Center